Optimized blood thinner therapy after heart stent placement
Part of Heart & circulation clinical trials.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have evidence of reduced blood flow to the heart muscle, such as chest pain or a previous heart attack.
- The narrowed artery must be suitable for a specific type of stent (NeoVas), with the narrowing in a vessel that is 2.75 to 3.75 mm wide and not longer than 40 mm.
- You must be able to take aspirin and clopidogrel for the duration of the study.
- You must be willing to follow the study schedule and come for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests a new way of taking blood thinners after getting a stent. Instead of staying on two blood thinners for a long time, you switch earlier to just one (ticagrelor). This might reduce bleeding risks while still protecting against heart problems.
This study looks at whether taking just one blood-thinning medicine (instead of two) after a stent procedure helps prevent future heart problems while lowering the risk of bleeding. It's for people who recently had a heart attack or unstable chest pain and had a stent placed.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.